Translating Clinical Pharmacology Data in Pregnancy to Evidence-Based Guideline Recommendations: Perspectives From the HIV Field. [Review] - 2023

Available online from MWHC library: 1999 - present, Available in print through MWHC library: 1999 - 2006

Pharmacokinetic (PK) studies in pregnant, postpartum, and breastfeeding people are critical to informing appropriate medication use and dosing. A key component of translating PK results in these complex populations into clinical practice involves the systematic review and interpretation of data by guideline panels, composed of clinicians, scientists, and community members, to leverage available data for informed decision making by clinicians and patients and offer clinical best practices. Interpretation of PK data in pregnancy involves evaluation of multiple factors such as the study design, target population, and type of sampling performed. Assessments of fetal and infant drug exposure while in utero or during breastfeeding, respectively, are also critical for informing whether medications are safe to use during pregnancy and throughout postpartum in lactating people. This review will provide an overview of this translational process, discussion of the various factors considered by guideline panels, and practical aspects of implementing certain recommendations, using the HIV field as an example. Copyright © 2023, The American College of Clinical Pharmacology.


English

0091-2700

10.1002/jcph.2240 [doi]


*HIV Infections
*Pharmacology, Clinical
Breast Feeding
Female
Fetus
HIV Infections/dt [Drug Therapy]
Humans
Infant
Lactation
Pregnancy--Automated


MedStar Washington Hospital Center


Obstetrics and Gynecology


Journal Article
Review